Inhaled drug delivery forms the basis of many respiratory disease treatment regimes. With further development of inhaled drug delivery technology, we could both improve the treatment of these diseases, and enable the delivery of a wider range of active substances for more and more conditions.

Inhalation therapy is the foundation of treatment for many respiratory diseases, such as COPD and asthma, affecting hundreds of millions globally. However, there is a need for innovation that addresses the limitations of existing approaches and expands the benefits of inhalation therapy into areas outside of respiratory disease.